Cellular biomarkers of endothelial health: Microparticles, endothelial progenitor cells, and circulating endothelial cells

Journal of the American Society of Hypertension

Volumn 6, Issue 2, 2012, Pages 85-99

  Burger, Dylan ^a   Touyz, Rhian M ^a  

^a OTTAWA HOSPITAL RESEARCH INSTITUTE   (Canada)

Author keywords

circulating endothelial cells; endothelial; endothelial dysfunction; Microparticles; progenitor

Indexed keywords

3 NITROTYROSINE; 6 OXOPROSTAGLANDIN F1 ALPHA; BIOLOGICAL MARKER; C REACTIVE PROTEIN; FIBRINOGEN; INTERLEUKIN 6; ISOPROSTANE DERIVATIVE; N(G),N(G) DIMETHYLARGININE; NITRIC OXIDE; PADGEM PROTEIN; PROSTACYCLIN; THIOBARBITURIC ACID REACTIVE SUBSTANCE; THROMBOMODULIN; TUMOR NECROSIS FACTOR ALPHA; VASCULAR CELL ADHESION MOLECULE 1;

BLOOD CLOTTING; CATABOLISM; CELL ADHESION; CIRCULATING ENDOTHELIAL CELL; DEGRADATION KINETICS; DIAGNOSTIC VALUE; ENDOTHELIAL DYSFUNCTION; ENDOTHELIAL MICROPARTICLE; ENDOTHELIAL PROGENITOR CELL; ENDOTHELIUM CELL; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; IMMUNOASSAY; INFLAMMATION; LIPID PEROXIDATION; MASS FRAGMENTOGRAPHY; NONHUMAN; OXIDATIVE STRESS; PARTICLE SIZE; PHENOTYPE; PRIORITY JOURNAL; REVIEW; SPECTROPHOTOMETRY;

BIOLOGICAL MARKERS; CELL-DERIVED MICROPARTICLES; ENDOTHELIUM, VASCULAR; HEMATOPOIETIC STEM CELLS; HUMANS; HYPERTENSION; RISK FACTORS;

EID: 84858706220     PISSN: 19331711     EISSN: 18787436     Source Type: Journal    
DOI: 10.1016/j.jash.2011.11.003     Document Type: Review

References (164)

1. D.H. Endemann, and E.L. Schiffrin Endothelial dysfunction J Am Soc Nephrol 15 2004 1983 1992 (Pubitemid 39031337)
2. I.A. van den Oever, H.G. Raterman, M.T. Nurmohamed, and S. Simsek Endothelial dysfunction, inflammation, and apoptosis in diabetes mellitus Mediators Inflamm 2010 2010 792393
3. A.J. Flammer, and T.F. Luscher Three decades of endothelium research: from the detection of nitric oxide to the everyday implementation of endothelial function measurements in cardiovascular diseases Swiss Med Wkly 140 2010 w13122
4. T. Nakagawa, K. Tanabe, B.P. Croker, R.J. Johnson, M.B. Grant, and T. Kosugi Endothelial dysfunction as a potential contributor in diabetic nephropathy Nat Rev Nephrol 7 2010 36 44
5. A. Virdis, L. Ghiadoni, and S. Taddei Effects of antihypertensive treatment on endothelial function Curr Hypertens Rep 13 2011 276 281
6. D. Versari, E. Daghini, A. Virdis, L. Ghiadoni, and S. Taddei Endothelium-dependent contractions and endothelial dysfunction in human hypertension Br J Pharmacol 157 2009 527 536
7. J. Calles-Escandon, and M. Cipolla Diabetes and endothelial dysfunction: a clinical perspective Endocr Rev 22 2001 36 52 (Pubitemid 32187802)
8. S. Taddei, A. Virdis, L. Ghiadoni, P. Mattei, I. Sudano, and G. Bernini Menopause is associated with endothelial dysfunction in women Hypertension 28 1996 576 582 (Pubitemid 26327952)
9. G. Kerekes, Z. Szekanecz, H. Der, Z. Sandor, G. Lakos, and L. Muszbek Endothelial dysfunction and atherosclerosis in rheumatoid arthritis: a multiparametric analysis using imaging techniques and laboratory markers of inflammation and autoimmunity J Rheumatol 35 2008 398 406 (Pubitemid 351374411)
10. K. Peters, R.E. Unger, J. Brunner, and C.J. Kirkpatrick Molecular basis of endothelial dysfunction in sepsis Cardiovasc Res 60 2003 49 57 (Pubitemid 38373475)
11. P.M. Vanhoutte Aging and vascular responsiveness J Cardiovasc Pharmacol 12 Suppl 8 1988 S11 S19
12. P.M. Vanhoutte Ageing and endothelial dysfunction Eur Heart J Suppl 4 suppl A 2002 A8 A17
13. J. Lee, K.C. Choi, C.H. Yeum, W. Kim, K. Yoo, and J.W. Park Impairment of endothelium-dependent vasorelaxation in chronic two-kidney, one clip hypertensive rats Nephrol Dial Transplant 10 1995 619 623
14. J. Thambyrajah, M.J. Landray, F.J. McGlynn, H.J. Jones, D.C. Wheeler, and J.N. Townend Abnormalities of endothelial function in patients with predialysis renal failure Heart 83 2000 205 209 (Pubitemid 30305552)
15. M.J. Landray, D.C. Wheeler, G.Y. Lip, D.J. Newman, A.D. Blann, and F.J. McGlynn Inflammation, endothelial dysfunction, and platelet activation in patients with chronic kidney disease: the Chronic Renal Impairment in Birmingham (CRIB) study Am J Kidney Dis 43 2004 244 253 (Pubitemid 38146322)
16. D.J. Stewart, and J.C. Monge Hyperlipidemia and endothelial dysfunction. Current Opinion in Lipidology 1993 Lippincott, Williams, and Wilkins London
17. M. Knecht, D. Burkhoff, G.H. Yi, S. Popilskis, S. Homma, and M. Packer Coronary endothelial dysfunction precedes heart failure and reduction of coronary reserve in awake dogs J Mol Cell Cardiol 29 1997 217 227 (Pubitemid 27129145)
18. G. Szucs, O. Timar, Z. Szekanecz, H. Der, G. Kerekes, and S. Szamosi Endothelial dysfunction precedes atherosclerosis in systemic sclerosis - relevance for prevention of vascular complications Rheumatology (Oxford) 46 2007 759 762 (Pubitemid 47061704)
19. C.D. Stehouwer, H.R. Fischer, A.W. van Kuijk, B.C. Polak, and A.J. Donker Endothelial dysfunction precedes development of microalbuminuria in IDDM Diabetes 44 1995 561 564
20. R.A. Stein Endothelial dysfunction, erectile dysfunction, and coronary heart disease: the pathophysiologic and clinical linkage Rev Urol 5 Suppl 7 2003 S21 S27
21. T.J. Anderson, F. Charbonneau, L.M. Title, J. Buithieu, M.S. Rose, and H. Conradson Microvascular function predicts cardiovascular events in primary prevention: long-term results from the Firefighters and Their Endothelium (FATE) study Circulation 123 2011 163 169
22. M. Shechter, S. Matetzky, M. Arad, M.S. Feinberg, and D. Freimark Vascular endothelial function predicts mortality risk in patients with advanced ischaemic chronic heart failure Eur J Heart Fail 11 2009 588 593
23. J. Yeboah, J.R. Crouse, F.C. Hsu, G.L. Burke, and D.M. Herrington Brachial flow-mediated dilation predicts incident cardiovascular events in older adults: the Cardiovascular Health Study Circulation 115 2007 2390 2397 (Pubitemid 46717961)
24. J. Yeboah, K. Sutton-Tyrrell, M.A. McBurnie, G.L. Burke, D.M. Herrington, and J.R. Crouse Association between brachial artery reactivity and cardiovascular disease status in an elderly cohort: the Cardiovascular Health Study Atherosclerosis 197 2008 768 776 (Pubitemid 351417874)
25. T.F. Luscher, P.M. Vanhoutte, and L. Raij Antihypertensive treatment normalizes decreased endothelium-dependent relaxations in rats with salt-induced hypertension Hypertension 9 1987 III193 III197
26. Y. Dohi, L. Criscione, K. Pfeiffer, and T.F. Luscher Angiotensin blockade or calcium antagonists improve endothelial dysfunction in hypertension: studies in perfused mesenteric resistance arteries J Cardiovasc Pharmacol 24 1994 372 379 (Pubitemid 24260516)
27. T.F. Luscher, F.C. Tanner, and G. Noll Lipids and endothelial function: effects of lipid-lowering and other therapeutic interventions Curr Opin Lipidol 7 1996 234 240 (Pubitemid 26280233)
28. R. Hambrecht, L. Hilbrich, S. Erbs, S. Gielen, E. Fiehn, and N. Schoene Correction of endothelial dysfunction in chronic heart failure: additional effects of exercise training and oral L-arginine supplementation J Am Coll Cardiol 35 2000 706 713 (Pubitemid 30167028)
29. R. Hambrecht, E. Fiehn, C. Weigl, S. Gielen, C. Hamann, and R. Kaiser Regular physical exercise corrects endothelial dysfunction and improves exercise capacity in patients with chronic heart failure Circulation 98 1998 2709 2715 (Pubitemid 28564006)
30. R.D. Fish, E.G. Nabel, A.P. Selwyn, P.L. Ludmer, G.H. Mudge, and J.M. Kirshenbaum Responses of coronary arteries of cardiac transplant patients to acetylcholine J Clin Invest 81 1988 21 31 (Pubitemid 18092228)
31. P.L. Ludmer, A.P. Selwyn, T.L. Shook, R.R. Wayne, G.H. Mudge, and R.W. Alexander Paradoxical vasoconstriction induced by acetylcholine in atherosclerotic coronary arteries N Engl J Med 315 1986 1046 1051 (Pubitemid 17170620)
32. N. Benjamin, A. Calver, J. Collier, B. Robinson, P. Vallance, and D. Webb Measuring forearm blood flow and interpreting the responses to drugs and mediators Hypertension 25 1995 918 923
33. D.S. Celermajer, K.E. Sorensen, V.M. Gooch, D.J. Spiegelhalter, O.I. Miller, and I.D. Sullivan Non-invasive detection of endothelial dysfunction in children and adults at risk of atherosclerosis Lancet 340 1992 1111 1115
34. K.E. Sorensen, D.S. Celermajer, D.J. Spiegelhalter, D. Georgakopoulos, J. Robinson, and O. Thomas Non-invasive measurement of human endothelium dependent arterial responses: accuracy and reproducibility Br Heart J 74 1995 247 253
35. F. Khan, and J.D. Coffman Enhanced cholinergic cutaneous vasodilation in Raynaud's phenomenon Circulation 89 1994 1183 1188 (Pubitemid 24076544)
36. P.O. Bonetti, G.W. Barsness, P.C. Keelan, T.I. Schnell, G.M. Pumper, and J.T. Kuvin Enhanced external counterpulsation improves endothelial function in patients with symptomatic coronary artery disease J Am Coll Cardiol 41 2003 1761 1768 (Pubitemid 36584250)
37. J.J. Oliver, and D.J. Webb Noninvasive assessment of arterial stiffness and risk of atherosclerotic events Arterioscler Thromb Vasc Biol 23 2003 554 566 (Pubitemid 36438066)
38. M. Juonala, J.S. Viikari, T. Laitinen, J. Marniemi, H. Helenius, and T. Ronnemaa Interrelations between brachial endothelial function and carotid intima-media thickness in young adults: the Cardiovascular Risk in Young Finns study Circulation 110 2004 2918 2923 (Pubitemid 39473618)
39. J. Deanfield, A. Donald, C. Ferri, C. Giannattasio, J. Halcox, and S. Halligan Endothelial function and dysfunction. Part I: methodological issues for assessment in the different vascular beds: a statement by the Working Group on Endothelin and Endothelial Factors of the European Society of Hypertension J Hypertens 23 2005 7 17 (Pubitemid 40128972)
40. C. Savoia, R.M. Touyz, F. Amiri, and E.L. Schiffrin Selective mineralocorticoid receptor blocker eplerenone reduces resistance artery stiffness in hypertensive patients Hypertension 51 2008 432 439 (Pubitemid 351156429)
41. R.M. Touyz, X. Chen, F. Tabet, G. Yao, G. He, and M.T. Quinn Expression of a functionally active gp91phox-containing neutrophil-type NAD(P)H oxidase in smooth muscle cells from human resistance arteries: regulation by angiotensin II Circ Res 90 2002 1205 1213 (Pubitemid 34786906)
42. S. Kawashima The two faces of endothelial nitric oxide synthase in the pathophysiology of atherosclerosis Endothelium 11 2004 99 107 (Pubitemid 39207183)
43. Q. Feng, and T. Hedner Endothelium-derived relaxing factor (EDRF) and nitric oxide (NO). I. Physiology, pharmacology and pathophysiological implications Clin Physiol 10 1990 407 426 (Pubitemid 20302935)
44. Q. Feng, and T. Hedner Endothelium-derived relaxing factor (EDRF) and nitric oxide (NO). II. Physiology, pharmacology and pathophysiological implications Clin Physiol 10 1990 503 526 (Pubitemid 20377838)
45. E. Nagababu, and J.M. Rifkind Measurement of plasma nitrite by chemiluminescence Methods Mol Biol 610 2010 41 49
46. G.A. Zeballos, R.D. Bernstein, C.I. Thompson, P.R. Forfia, N. Seyedi, and W. Shen Pharmacodynamics of plasma nitrate/nitrite as an indication of nitric oxide formation in conscious dogs Circulation 91 1995 2982 2988
47. D.P. Casey, D.T. Beck, and R.W. Braith Systemic plasma levels of nitrite/nitrate (NOx) reflect brachial flow-mediated dilation responses in young men and women Clin Exp Pharmacol Physiol 34 2007 1291 1293 (Pubitemid 350013239)
48. T. Rassaf, C. Heiss, U. Hendgen-Cotta, J. Balzer, S. Matern, and P. Kleinbongard Plasma nitrite reserve and endothelial function in the human forearm circulation Free Radic Biol Med 41 2006 295 301 (Pubitemid 43928502)
49. M. Kelm, H. Preik-Steinhoff, M. Preik, and B.E. Strauer Serum nitrite sensitively reflects endothelial NO formation in human forearm vasculature: evidence for biochemical assessment of the endothelial L-arginine-NO pathway Cardiovasc Res 41 1999 765 772 (Pubitemid 29130641)
50. F. Saijo, A.B. Milsom, N.S. Bryan, S.M. Bauer, T. Vowinkel, and M. Ivanovic On the dynamics of nitrite, nitrate and other biomarkers of nitric oxide production in inflammatory bowel disease Nitric Oxide 22 2010 155 167
51. T. Teerlink, Z. Luo, F. Palm, and C.S. Wilcox Cellular ADMA: regulation and action Pharmacol Res 60 2009 448 460
52. M. Juonala, J.S. Viikari, G. Alfthan, J. Marniemi, M. Kahonen, and L. Taittonen Brachial artery flow-mediated dilation and asymmetrical dimethylarginine in the Cardiovascular Risk in Young Finns study Circulation 116 2007 1367 1373 (Pubitemid 47417562)
53. H. Paiva, M. Kahonen, T. Lehtimaki, G. Alfthan, J. Viikari, and R. Laaksonen Levels of asymmetrical dimethylarginine are predictive of brachial artery flow-mediated dilation 6 years later. The Cardiovascular Risk in Young Finns Study Atherosclerosis 212 2010 512 515
54. C. Baylis Arginine, arginine analogs and nitric oxide production in chronic kidney disease Nat Clin Pract Nephrol 2 2006 209 220 (Pubitemid 43787287)
55. A. Doroszko, R. Andrzejak, and A. Szuba Role of the nitric oxide metabolic pathway and prostanoids in the pathogenesis of endothelial dysfunction and essential hypertension in young men Hypertens Res 34 2011 79 86
56. M.S. Wolin, S.A. Gupte, B.H. Neo, Q. Gao, and M. Ahmad Oxidant-redox regulation of pulmonary vascular responses to hypoxia and nitric oxide-cGMP signaling Cardiol Rev 18 2010 89 93
57. V.B. O'Donnell, P.H. Chumley, N. Hogg, A. Bloodsworth, V.M. Darley-Usmar, and B.A. Freeman Nitric oxide inhibition of lipid peroxidation: kinetics of reaction with lipid peroxyl radicals and comparison with alpha-tocopherol Biochemistry 36 1997 15216 15223 (Pubitemid 27527986)
58. L.J. Roberts, and J.D. Morrow Measurement of F(2)-isoprostanes as an index of oxidative stress in vivo Free Radic Biol Med 28 2000 505 513 (Pubitemid 30136031)
59. D. Armstrong, and R. Browne The analysis of free radicals, lipid peroxides, antioxidant enzymes and compounds related to oxidative stress as applied to the clinical chemistry laboratory Adv Exp Med Biol 366 1994 43 58
60. A. Ceriello, F. Mercuri, L. Quagliaro, R. Assaloni, E. Motz, and L. Tonutti Detection of nitrotyrosine in the diabetic plasma: evidence of oxidative stress Diabetologia 44 2001 834 838 (Pubitemid 32642455)
61. M. White, A. Ducharme, R. Ibrahim, L. Whittom, J. Lavoie, and M.C. Guertin Increased systemic inflammation and oxidative stress in patients with worsening congestive heart failure: improvement after short-term inotropic support Clin Sci (Lond) 110 2006 483 489
62. T. Heitzer, T. Schlinzig, K. Krohn, T. Meinertz, and T. Munzel Endothelial dysfunction, oxidative stress, and risk of cardiovascular events in patients with coronary artery disease Circulation 104 2001 2673 2678 (Pubitemid 33108132)
63. M. Annuk, M. Zilmer, L. Lind, T. Linde, and B. Fellstrom Oxidative stress and endothelial function in chronic renal failure J Am Soc Nephrol 12 2001 2747 2752 (Pubitemid 33115422)
64. M. Annuk, M. Zilmer, and B. Fellstrom Endothelium-dependent vasodilation and oxidative stress in chronic renal failure: impact on cardiovascular disease Kidney Int Suppl 84 2003 S50 S53
65. S. Xiao, L. Wagner, J. Mahaney, and C. Baylis Uremic levels of urea inhibit L-arginine transport in cultured endothelial cells Am J Physiol Renal Physiol 280 2001 F989 F995
66. M. Kanbay, M.I. Yilmaz, A. Sonmez, F. Turgut, M. Saglam, and E. Cakir Serum uric acid level and endothelial dysfunction in patients with nondiabetic chronic kidney disease Am J Nephrol 33 2011 298 304
67. K. Bhagat, and P. Vallance Inflammatory cytokines impair endothelium-dependent dilatation in human veins in vivo Circulation 96 1997 3042 3047 (Pubitemid 27500106)
68. K. Raza, J. Thambyrajah, J.N. Townend, A.R. Exley, C. Hortas, and A. Filer Suppression of inflammation in primary systemic vasculitis restores vascular endothelial function: lessons for atherosclerotic disease? Circulation 102 2000 1470 1472
69. H. Ando, J. Zhou, M. Macova, H. Imboden, and J.M. Saavedra Angiotensin II AT1 receptor blockade reverses pathological hypertrophy and inflammation in brain microvessels of spontaneously hypertensive rats Stroke 35 2004 1726 1731 (Pubitemid 38823655)
70. M. Richardson, S.J. Hadcock, M. DeReske, and M.I. Cybulsky Increased expression in vivo of VCAM-1 and E-selectin by the aortic endothelium of normolipemic and hyperlipemic diabetic rabbits Arterioscler Thromb 14 1994 760 769
71. M. Guarneri, R. Riccobene, R. Arsena, C. Altieri, F. Tornese, and A. Previti Flow mediated dilation, endothelial and inflammatory biomarkers in hypertensives with chronic kidney disease J Hypertens 28 2010 e118
72. J.A. de Lemos, C.H. Hennekens, and P.M. Ridker Plasma concentration of soluble vascular cell adhesion molecule-1 and subsequent cardiovascular risk J Am Coll Cardiol 36 2000 423 426
73. P.M. Ridker, C.H. Hennekens, B. Roitman-Johnson, M.J. Stampfer, and J. Allen Plasma concentration of soluble intercellular adhesion molecule 1 and risks of future myocardial infarction in apparently healthy men Lancet 351 1998 88 92 (Pubitemid 28026634)
74. A. Recio-Mayoral, D. Banerjee, C. Streather, and J.C. Kaski Endothelial dysfunction, inflammation and atherosclerosis in chronic kidney disease - a cross-sectional study of predialysis, dialysis and kidney-transplantation patients Atherosclerosis 216 2011 446 451
75. J.Y. Yeun, R.A. Levine, V. Mantadilok, and G.A. Kaysen C-reactive protein predicts all-cause and cardiovascular mortality in hemodialysis patients Am J Kidney Dis 35 2000 469 476 (Pubitemid 30124077)
76. P. Ferroni, and F. Guadagni Soluble CD40L and its role in essential hypertension: diagnostic and therapeutic implications Cardiovasc Hematol Disord Drug Targets 8 2008 194 202
77. R.B. Goldberg Cytokine and cytokine-like inflammation markers, endothelial dysfunction, and imbalanced coagulation in development of diabetes and its complications J Clin Endocrinol Metab 94 2009 3171 3182
78. B.R. Binder, G. Christ, F. Gruber, N. Grubic, P. Hufnagl, and M. Krebs Plasminogen activator inhibitor 1: physiological and pathophysiological roles News Physiol Sci 17 2002 56 61
79. P. Yang, Y.F. Liu, L. Yang, Q. Wei, and H. Zeng Mechanism and clinical significance of the prothrombotic state in patients with essential hypertension Clin Cardiol 33 2010 E81 E86
80. G.Y. Lip, and A. Blann von Willebrand factor: a marker of endothelial dysfunction in vascular disorders? Cardiovasc Res 34 1997 255 265 (Pubitemid 27241568)
81. P. Paulinska, A. Spiel, and B. Jilma Role of von Willebrand factor in vascular disease Hamostaseologie 29 2009 32 38
82. A.O. Spiel, J.C. Gilbert, and B. Jilma von Willebrand factor in cardiovascular disease: focus on acute coronary syndromes Circulation 117 2008 1449 1459 (Pubitemid 351501497)
83. A.A. Meyer, G. Kundt, M. Steiner, P. Schuff-Werner, and W. Kienast Impaired flow-mediated vasodilation, carotid artery intima-media thickening, and elevated endothelial plasma markers in obese children: the impact of cardiovascular risk factors Pediatrics 117 2006 1560 1567 (Pubitemid 46071382)
84. V. Schiano, E. Laurenzano, G. Brevetti, J.I. De Maio, S. Lanero, and F. Scopacasa Omega-3 polyunsaturated fatty acid in peripheral arterial disease: effect on lipid pattern, disease severity, inflammation profile, and endothelial function Clin Nutr 27 2008 241 247
85. M.S. Goligorsky Clinical assessment of endothelial dysfunction: combine and rule Curr Opin Nephrol Hypertens 15 2006 617 624 (Pubitemid 44607434)
86. S. Kathiresan, P. Gona, M.G. Larson, J.A. Vita, G.F. Mitchell, and G.H. Tofler Cross-sectional relations of multiple biomarkers from distinct biological pathways to brachial artery endothelial function Circulation 113 2006 938 945 (Pubitemid 43879468)
87. T. Nozaki, S. Sugiyama, H. Koga, K. Sugamura, K. Ohba, and Y. Matsuzawa Significance of a multiple biomarkers strategy including endothelial dysfunction to improve risk stratification for cardiovascular events in patients at high risk for coronary heart disease J Am Coll Cardiol 54 2009 601 608
88. F. Dignat-George, and C.M. Boulanger The many faces of endothelial microparticles Arterioscler Thromb Vasc Biol 31 2011 27 33
89. C. Beyer, and D.S. Pisetsky The role of microparticles in the pathogenesis of rheumatic diseases Nat Rev Rheumatol 6 2010 21 29
90. C. Thery, M. Ostrowski, and E. Segura Membrane vesicles as conveyors of immune responses Nat Rev Immunol 9 2009 581 593
91. M. Simons, and G. Raposo Exosomes - vesicular carriers for intercellular communication Curr Opin Cell Biol 21 2009 575 581
92. H.D. Halicka, E. Bedner, and Z. Darzynkiewicz Segregation of RNA and separate packaging of DNA and RNA in apoptotic bodies during apoptosis Exp Cell Res 260 2000 248 256
93. J.F. Kerr History of the events leading to the formulation of the apoptosis concept Toxicology 181-182 2002 471 474 (Pubitemid 36015740)
94. W. Jy, L.L. Horstman, J.J. Jimenez, Y.S. Ahn, E. Biro, and R. Nieuwland Measuring circulating cell-derived microparticles J Thromb Haemost 2 2004 1842 1851 (Pubitemid 40197488)
95. R. Lacroix, S. Robert, P. Poncelet, and F. Dignat-George Overcoming limitations of microparticle measurement by flow cytometry Semin Thromb Hemost 36 2010 807 818
96. D. Burger, A.C. Montezano, N. Nishigaki, Y. He, A. Carter, and R.M. Touyz Endothelial microparticle formation by angiotensin II is mediated via AT1R/NADPH oxidase/rho kinase pathways targeted to lipid rafts Arterioscler Thromb Vasc Biol 31 2011 1898 1907
97. A. Duval, D. Helley, L. Capron, P. Youinou, Y. Renaudineau, and S. Dubucquoi Endothelial dysfunction in systemic lupus patients with low disease activity: evaluation by quantification and characterization of circulating endothelial microparticles, role of anti-endothelial cell antibodies Rheumatology (Oxford) 49 2010 1049 1055
98. G.N. Chironi, C.M. Boulanger, A. Simon, F. Dignat-George, J.M. Freyssinet, and A. Tedgui Endothelial microparticles in diseases Cell Tissue Res 335 2009 143 151
99. A.S. Leroyer, F. Anfosso, R. Lacroix, F. Sabatier, S. Simoncini, and S.M. Njock Endothelial-derived microparticles: biological conveyors at the crossroad of inflammation, thrombosis and angiogenesis Thromb Haemost 104 2010 456 463
100. L.C. Azevedo, M.A. Pedro, and F.R. Laurindo Circulating microparticles as therapeutic targets in cardiovascular diseases Recent Pat Cardiovasc Drug Discov 2 2007 41 51 (Pubitemid 46813415)
101. E. Shantsila, P.W. Kamphuisen, and G.Y. Lip Circulating microparticles in cardiovascular disease: implications for atherogenesis and atherothrombosis J Thromb Haemost 8 2010 2358 2368
102. C.M. Boulanger, N. Amabile, and A. Tedgui Circulating microparticles: a potential prognostic marker for atherosclerotic vascular disease Hypertension 48 2006 180 186 (Pubitemid 44309805)
103. K. Esposito, M. Ciotola, F. Giugliano, B. Schisano, L. Improta, and M.R. Improta Endothelial microparticles correlate with erectile dysfunction in diabetic men Int J Impot Res 19 2007 161 166 (Pubitemid 46340832)
104. K. Esposito, M. Ciotola, B. Schisano, R. Gualdiero, L. Sardelli, and L. Misso Endothelial microparticles correlate with endothelial dysfunction in obese women J Clin Endocrinol Metab 91 2006 3676 3679 (Pubitemid 44402155)
105. N. Amabile, C. Heiss, V. Chang, F.S. Angeli, L. Damon, and E.J. Rame Increased CD62e(+) endothelial microparticle levels predict poor outcome in pulmonary hypertension patients J Heart Lung Transplant 28 2009 1081 1086
106. B. Pannier, A. Guerin, N. Amabile, C. Boulanger, A. Tedgui, and G. London Circulating endothelial microparticles predict cardiovascular mortality in end-stage renal disease: 3A.06 J Hypertens 28 2010 e30
107. P.E. Rautou, A.S. Leroyer, B. Ramkhelawon, C. Devue, D. Duflaut, and A.C. Vion Microparticles from human atherosclerotic plaques promote endothelial ICAM-1-dependent monocyte adhesion and transendothelial migration Circ Res 108 2011 335 343
108. S. Tual-Chalot, C. Guibert, B. Muller, J.P. Savineau, R. Andriantsitohaina, and M.C. Martinez Circulating microparticles from pulmonary hypertensive rats induce endothelial dysfunction Am J Respir Crit Care Med 182 2010 261 268
109. F. Meziani, A. Tesse, and R. Andriantsitohaina Microparticles are vectors of paradoxical information in vascular cells including the endothelium: role in health and diseases Pharmacol Rep 60 2008 75 84 (Pubitemid 351586545)
110. U. Erdbruegger, M. Haubitz, and A. Woywodt Circulating endothelial cells: a novel marker of endothelial damage Clin Chim Acta 373 2006 17 26 (Pubitemid 44292176)
111. A. Woywodt, F. Streiber, K. de Groot, H. Regelsberger, H. Haller, and M. Haubitz Circulating endothelial cells as markers for ANCA-associated small-vessel vasculitis Lancet 361 2003 206 210 (Pubitemid 36126220)
112. M. Hasmim, G. Vassalli, G.C. Alghisi, J. Bamat, L. Ponsonnet, and G. Bieler Expressed isolated integrin beta1 subunit cytodomain induces endothelial cell death secondary to detachment Thromb Haemost 94 2005 1060 1070 (Pubitemid 41645950)
113. S.M. Frisch, and E. Ruoslahti Integrins and anoikis Curr Opin Cell Biol 9 1997 701 706 (Pubitemid 27424927)
114. S.S. Khan, M.A. Solomon, and J.P. McCoy Jr. Detection of circulating endothelial cells and endothelial progenitor cells by flow cytometry Cytometry B Clin Cytom 64 2005 1 8 (Pubitemid 40960406)
115. M.S. Segal, A. Bihorac, and M. Koc Circulating endothelial cells: tea leaves for renal disease Am J Physiol Renal Physiol 283 2002 F11 F19
116. C.J. Boos, D.A. Lane, M. Karpha, D.G. Beevers, R. Haynes, and G.Y. Lip Circulating endothelial cells, arterial stiffness, and cardiovascular risk stratification in hypertension Chest 132 2007 1540 1547 (Pubitemid 350156011)
117. M. Koc, A. Bihorac, and M.S. Segal Circulating endothelial cells as potential markers of the state of the endothelium in hemodialysis patients Am J Kidney Dis 42 2003 704 712 (Pubitemid 37187370)
118. J.A. McClung, N. Naseer, M. Saleem, G.P. Rossi, M.B. Weiss, and N.G. Abraham Circulating endothelial cells are elevated in patients with type 2 diabetes mellitus independently of HbA(1)c Diabetologia 48 2005 345 350 (Pubitemid 40543308)
119. B. Canbakan, K. Keven, H. Tutkak, N. Danisman, I. Ergun, and G. Nergizoglu Circulating endothelial cells in preeclampsia J Hum Hypertens 21 2007 558 563 (Pubitemid 47018630)
120. A.Y. Chong, A.D. Blann, J. Patel, B. Freestone, E. Hughes, and G.Y. Lip Endothelial dysfunction and damage in congestive heart failure: relation of flow-mediated dilation to circulating endothelial cells, plasma indexes of endothelial damage, and brain natriuretic peptide Circulation 110 2004 1794 1798 (Pubitemid 39302656)
121. K.W. Lee, A.D. Blann, and G.Y. Lip Inter-relationships of indices of endothelial damage/dysfunction [circulating endothelial cells, von Willebrand factor and flow-mediated dilatation] to tissue factor and interleukin-6 in acute coronary syndromes Int J Cardiol 111 2006 302 308 (Pubitemid 44107573)
122. M. Koc, H.B. Richards, A. Bihorac, E.A. Ross, J.D. Schold, and M.S. Segal Circulating endothelial cells are associated with future vascular events in hemodialysis patients Kidney Int 67 2005 1078 1083 (Pubitemid 41623333)
123. K.W. Lee, G.Y. Lip, M. Tayebjee, W. Foster, and A.D. Blann Circulating endothelial cells, von Willebrand factor, interleukin-6, and prognosis in patients with acute coronary syndromes Blood 105 2005 526 532 (Pubitemid 40070731)
124. N. Del Papa, M. Cortiana, C. Vitali, I. Silvestris, W. Maglione, and D.P. Comina Simvastatin reduces endothelial activation and damage but is partially ineffective in inducing endothelial repair in systemic sclerosis J Rheumatol 35 2008 1323 1328 (Pubitemid 352000778)
125. S. Sen, S.P. McDonald, P.T. Coates, and C.S. Bonder Endothelial progenitor cells: novel biomarker and promising cell therapy for cardiovascular disease Clin Sci (Lond) 120 2011 263 283
126. F. Sabatier, L. Camoin-Jau, F. Anfosso, J. Sampol, and F. Dignat-George Circulating endothelial cells, microparticles and progenitors: key players towards the definition of vascular competence J Cell Mol Med 13 2009 454 471
127. D.A. Ingram, N.M. Caplice, and M.C. Yoder Unresolved questions, changing definitions, and novel paradigms for defining endothelial progenitor cells Blood 106 2005 1525 1531 (Pubitemid 41208561)
128. M.C. Yoder Defining human endothelial progenitor cells J Thromb Haemost 7 Suppl 1 2009 49 52
129. R.J. Medina, C.L. O'Neill, M.W. Humphreys, T.A. Gardiner, and A.W. Stitt Outgrowth endothelial cells: characterization and their potential for reversing ischemic retinopathy Invest Ophthalmol Vis Sci 51 2010 5906 5913
130. R.J. Medina, C.L. O'Neill, M. Sweeney, J. Guduric-Fuchs, T.A. Gardiner, and D.A. Simpson Molecular analysis of endothelial progenitor cell (EPC) subtypes reveals two distinct cell populations with different identities BMC Med Genom 3 2011 18
131. J.H. Choi, K.L. Kim, W. Huh, B. Kim, J. Byun, and W. Suh Decreased number and impaired angiogenic function of endothelial progenitor cells in patients with chronic renal failure Arterioscler Thromb Vasc Biol 24 2004 1246 1252 (Pubitemid 38880016)
132. O.M. Tepper, R.D. Galiano, J.M. Capla, C. Kalka, P.J. Gagne, and G.R. Jacobowitz Human endothelial progenitor cells from type II diabetics exhibit impaired proliferation, adhesion, and incorporation into vascular structures Circulation 106 2002 2781 2786 (Pubitemid 35396976)
133. C.J. Loomans, H.H. Dao, A.J. van Zonneveld, and T.J. Rabelink Is endothelial progenitor cell dysfunction involved in altered angiogenic processes in patients with hypertension? Curr Hypertens Rep 6 2004 51 54 (Pubitemid 39359542)
134. Z. Zhou, J. Peng, C.J. Wang, D. Li, T.T. Li, and C.P. Hu Accelerated senescence of endothelial progenitor cells in hypertension is related to the reduction of calcitonin gene-related peptide J Hypertens 28 2010 931 939
135. E. Magen, A. Feldman, Z. Cohen, D.B. Alon, L. Linov, and J. Mishal Potential link between C3a, C3b and endothelial progenitor cells in resistant hypertension Am J Med Sci 339 2010 415 419
136. J.Z. Chen, F.R. Zhang, Q.M. Tao, X.X. Wang, and J.H. Zhu Number and activity of endothelial progenitor cells from peripheral blood in patients with hypercholesterolaemia Clin Sci (Lond) 107 2004 273 280 (Pubitemid 39243886)
137. C. Heiss, S. Keymel, U. Niesler, J. Ziemann, M. Kelm, and C. Kalka Impaired progenitor cell activity in age-related endothelial dysfunction J Am Coll Cardiol 45 2005 1441 1448 (Pubitemid 40615616)
138. G.P. Fadini, C. Pagano, I. Baesso, O. Kotsafti, D. Doro, and S.V. de Kreutzenberg Reduced endothelial progenitor cells and brachial artery flow-mediated dilation as evidence of endothelial dysfunction in ocular hypertension and primary open-angle glaucoma Acta Ophthalmol 88 2010 135 141
139. J.M. Hill, G. Zalos, J.P. Halcox, W.H. Schenke, M.A. Waclawiw, and A.A. Quyyumi Circulating endothelial progenitor cells, vascular function, and cardiovascular risk N Engl J Med 348 2003 593 600 (Pubitemid 36204953)
140. C. Foresta, A. Ferlin, L. De Toni, A. Lana, C. Vinanzi, and A. Galan Circulating endothelial progenitor cells and endothelial function after chronic Tadalafil treatment in subjects with erectile dysfunction Int J Impot Res 18 2006 484 488 (Pubitemid 44330301)
141. N. Werner, S. Kosiol, T. Schiegl, P. Ahlers, K. Walenta, and A. Link Circulating endothelial progenitor cells and cardiovascular outcomes N Engl J Med 353 2005 999 1007 (Pubitemid 41262334)
142. C. Schmidt-Lucke, L. Rossig, S. Fichtlscherer, M. Vasa, M. Britten, and U. Kamper Reduced number of circulating endothelial progenitor cells predicts future cardiovascular events: proof of concept for the clinical importance of endogenous vascular repair Circulation 111 2005 2981 2987 (Pubitemid 40814192)
143. J. Chen, S. Chen, Y. Chen, C. Zhang, J. Wang, and W. Zhang Circulating endothelial progenitor cells and cellular membrane microparticles in db/db diabetic mouse: possible implications in cerebral ischemic damage Am J Physiol Endocrinol Metab 301 2011 E62 E71
144. C. Holmen, E. Elsheikh, P. Stenvinkel, A.R. Qureshi, E. Pettersson, and S. Jalkanen Circulating inflammatory endothelial cells contribute to endothelial progenitor cell dysfunction in patients with vasculitis and kidney involvement J Am Soc Nephrol 16 2005 3110 3120 (Pubitemid 44743509)
145. M. Pirro, G. Schillaci, R. Paltriccia, F. Bagaglia, C. Menecali, and M.R. Mannarino Increased ratio of CD31+/CD42- microparticles to endothelial progenitors as a novel marker of atherosclerosis in hypercholesterolemia Arterioscler Thromb Vasc Biol 26 2006 2530 2535 (Pubitemid 44607476)
146. M. Valgimigli, G.M. Rigolin, A. Fucili, M.D. Porta, O. Soukhomovskaia, and P. Malagutti CD34+ and endothelial progenitor cells in patients with various degrees of congestive heart failure Circulation 110 2004 1209 1212 (Pubitemid 39202334)
147. M.D. Shah, A.L. Bergeron, J.F. Dong, and J.A. Lopez Flow cytometric measurement of microparticles: pitfalls and protocol modifications Platelets 19 2008 365 372
148. A.D. Blann, A. Woywodt, F. Bertolini, T.M. Bull, J.P. Buyon, and R.M. Clancy Circulating endothelial cells. Biomarker of vascular disease Thromb Haemost 93 2005 228 235 (Pubitemid 40253726)
149. W.L. Dean, M.J. Lee, T.D. Cummins, D.J. Schultz, and D.W. Powell Proteomic and functional characterisation of platelet microparticle size classes Thromb Haemost 102 2009 711 718
150. W. Jy, L.L. Horstman, and Y.S. Ahn Microparticle size and its relation to composition, functional activity, and clinical significance Semin Thromb Hemost 36 2010 876 880
151. P. Davizon, and J.A. Lopez Microparticles and thrombotic disease Curr Opin Hematol 16 2009 334 341
152. T. Kirsch, A. Woywodt, M. Beese, K. Wyss, J.-K. Park, and U. Erdbruegger Engulfment of apoptotic cells by microvascular endothelial cells induces proinflammatory responses Blood 109 2007 2854 2862 (Pubitemid 46482081)
153. R. Flaumenhaft Formation and fate of platelet microparticles Blood Cells Mol Dis 36 2006 182 187
154. L. Bonello, A. Basire, F. Sabatier, F. Paganelli, and F. Dignat-George Endothelial injury induced by coronary angioplasty triggers mobilization of endothelial progenitor cells in patients with stable coronary artery disease J Thromb Haemost 4 2006 979 981
155. S. Devaraj, P.R. Kumaresan, and I. Jialal CRP induces release of both endothelial microparticles and circulating endothelial cells in vitro and in vivo: further evidence of endothelial dysfunction Clin Chem 57 2011 1757 1761
156. M.D. Brown, D.L. Feairheller, S. Thakkar, P. Veerabhadrappa, and J.Y. Park Racial differences in tumor necrosis factor-alpha-induced endothelial microparticles and interleukin-6 production Vasc Health Risk Manage 7 2011 541 550
157. D.B. Peterson, T. Sander, S. Kaul, B.T. Wakim, B. Halligan, and S. Twigger Comparative proteomic analysis of PAI-1 and TNF-alpha-derived endothelial microparticles Proteomics 8 2008 2430 2446
158. A.M. Curtis, L. Zhang, E. Medenilla, M. Gui, P.F. Wilkinson, and E. Hu Relationship of microparticles to progenitor cells as a measure of vascular health in a diabetic population Cytometry B Clin Cytom 78 2010 329 337
159. B.A. Garcia, D.M. Smalley, H. Cho, J. Shabanowitz, K. Ley, and D.F. Hunt The platelet microparticle proteome J Proteome Res 4 2005 1516 1521 (Pubitemid 41464776)
160. C. Banfi, M. Brioschi, R. Wait, S. Begum, E. Gianazza, and A. Pirillo Proteome of endothelial cell-derived procoagulant microparticles Proteomics 5 2005 4443 4455 (Pubitemid 41739922)
161. L. Miguet, K. Pacaud, C. Felden, B. Hugel, M.C. Martinez, and J.M. Freyssinet Proteomic analysis of malignant lymphocyte membrane microparticles using double ionization coverage optimization Proteomics 6 2006 153 171 (Pubitemid 43142942)
162. E. Ramacciotti, A.E. Hawley, S.K. Wrobleski, D.D. Myers Jr., J.R. Strahler, and P.C. Andrews Proteomics of microparticles after deep venous thrombosis Thromb Res 125 2010 e269 e274
163. N.M. Abdullah, M. Kachman, A. Walker, A.E. Hawley, S.K. Wrobleski, and D.D. Myers Microparticle surface protein are associated with experimental venous thrombosis: a preliminary study Clin Appl Thromb Hemost 15 2009 201 208
164. G. Pula, U. Mayr, C. Evans, M. Prokopi, D.S. Vara, and X. Yin Proteomics identifies thymidine phosphorylase as a key regulator of the angiogenic potential of colony-forming units and endothelial progenitor cell cultures Circ Res 104 2009 32 40